NGM Biopharmaceuticals Inc (NGM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
NGM Biopharmaceuticals, Inc. was notified by Nasdaq on January 18, 2024, that it has regained compliance with the minimum bid price requirement after its common stock’s closing bid price remained at $1.00 or above from January 2 to January 17, 2024. Consequently, the issue concerning its non-compliance with Nasdaq Listing Rule 5450(a)(1) has been resolved and the matter is closed.
For further insights into NGM stock, check out TipRanks’ Stock Analysis page.